e-VIS
e-VIS provides an e-verification system that prevents falsified medicines from reaching patients via pharmacies or healthcare.
The secure system helps ensure that every patient in Sweden can be confident the medicine they receive is authentic. e-VIS is supported by organisations within the entire medicine supply chain.
News
- Webinar on alert handling for MAHs the 2nd of February 2024
Welcome to e-VIS webinar for MAHs on investigation of alerts and Swedish recommendations, 2nd of February 2024 10.00-12.00 CET.The… Read More »Webinar on alert handling for MAHs the 2nd of February 2024 - The fight against falsified medicines
From December 4 to 10, Fight the fakes week is marked worldwide to raise awareness about the threat posed… Read More »The fight against falsified medicines - Updated end-user system support certification process
In the latest release of the Swedish e-verification system (SMVS), improvements have been made to simplify certification and testing… Read More »Updated end-user system support certification process - Falsified Ozempic on the European market
In Germany, wholesalers have by using the e-verification database and safety features detected falsified medicinal products in the supply… Read More »Falsified Ozempic on the European market - MAH fee 2024The adjusted flat fee per MAH 2024 remains unchanged compared to the 2023 fee.The annual fee for 2024: SEK 63 000 (currency: Swedish… Read More »MAH fee 2024
- The EAN code turns 50 – conversion from linear barcode to 2D code
The barcode was created in 1973. Since then, GS1, best known for the barcode, has been a guarantor of… Read More »The EAN code turns 50 – conversion from linear barcode to 2D code